Novo salvages happy ending for scrapped Parkinson’s cell therapy via deal with AI biotech

FierceBiotechAmid M&A buzz, Inhibrx's OX40-Keytruda combo shows promise in early look at midphase data

FierceBiotechDaiichi Sankyo targets global top 5 oncology rank by 2035, $1.3B efficiency drive in new 5-year plan

FDA News ReleasesFDA Advances Drug Repurposing to Address Unmet Medical Needs

Endpoints NewsBraveheart Bio's Hengrui-licensed cardiac drug scores second clinical win

BioPharma DiveBiotech layoffs are easing, but is the worst over?

FierceBiotechNovo salvages happy ending for scrapped Parkinson’s cell therapy via deal with AI biotech

BioWorldShanghai Jeyou Pharmaceutical patents LGALS3 inhibitors

BioWorldBoyuan Pharmaceutical prepares new HSV inhibitors

BioWorldAntimicrobial compounds revealed in University of Hong Kong patent

BioWorldYantai Rongchang Pharmaceutical reports new KRAS mutant inhibitors

BioWorldIn vivo mRNA gene therapy platform reprograms cytotoxic T cells

LabiotechInside CSL’s strategy to simplify a biotech giant